DivestmentJul 20, 2026, 04:41 PM
AdaptHealth Divests Diabetes Health Business for $235M
AI Summary
AdaptHealth Corp. announced it has entered into a definitive agreement to divest its Diabetes Health business to RGH Enterprises, LLC, a wholly owned subsidiary of Cardinal Health, Inc. The all-cash transaction is valued at $235.0 million, subject to customary post-closing adjustments. This strategic move aims to sharpen AdaptHealth's focus on its core sleep, respiratory, and supporting home medical equipment businesses, enhance capital flexibility for reinvestment and debt reduction, and is expected to improve the company's revenue growth profile and adjusted EBITDA margins.
Key Highlights
- AdaptHealth to divest its Diabetes Health business to Cardinal Health.
- Aggregate purchase price is $235.0 million in cash.
- Transaction is subject to customary closing conditions, including regulatory review.
- Company aims to focus on core sleep, respiratory, and home medical equipment businesses.
- Expected to improve AdaptHealth's revenue growth profile and adjusted EBITDA margins.
- Purchaser will deposit $8.0 million in escrow for post-closing adjustments.
- Purchaser will deposit $18.8 million in escrow for indemnification obligations.
- A termination fee of $9.4 million is payable by the Purchaser under certain conditions.
Price Impact
More from AHCO